Results 161 to 170 of about 7,584 (199)

Bacterial pore-forming toxin pneumolysin drives pathogenicity through host extracellular vesicles released during infection. [PDF]

iScience
Parveen S, Bhat CV, Sagilkumar AC, Aziz S, Arya J, Dutta A, Dutta S, Show S, Sharma K, Rakshit S, Johnson JB, Nongthomba U, Banerjee A, Subramanian K.   +13 more
europepmc   +1 more source

Structural investigations of pneumolysin/lipid complexes and pneumolysin-cholesterol interactions

, 2016
Bonev, B, Gilbert, R, Watts, A
openaire   +1 more source

Targeting PANoptosis in Bacterial-Induced Inflammatory Diseases: Mechanisms and Therapeutic Interventions. [PDF]

J Inflamm Res
Wang T, Lu Y, Zhang X, Yu F.
europepmc   +1 more source

Bacterial interactions with platelets: defining key themes. [PDF]

Front Immunol
Alfar HR, Whiteheart SW.
europepmc   +1 more source

Community-Acquired Necrotizing Pneumonia with Bronchopleural Fistulas Due to <i>Streptococcus pneumoniae</i> in an Adult. [PDF]

Infect Drug Resist
Li PJ, Yu MJ, Liu D.
europepmc   +1 more source

Pneumolysin contributes to dysfunction of nasal epithelial barrier for promotion of pneumococcal dissemination into brain tissue. [PDF]

mSphere
Takahara Y, Sumitomo T, Kono M, Takemura M, Akamatsu Y, Hirose Y, Yamaguchi M, Nakata M, Hotomi M, Kawabata S.   +9 more
europepmc   +1 more source

Pneumococcal pneumonia is driven by increased bacterial turnover due to bacteriocin-mediated intra-strain competition. [PDF]

Commun Biol
Aggarwal SD, Lokken-Toyli KL, Weiser JN.
europepmc   +1 more source

Preliminary Evaluation of the Safety and Immunogenicity of a Novel Protein-Based Pneumococcal Vaccine in Healthy Adults Aged 18-49: A Phase Ia Randomized, Double Blind, Placebo-Controlled Clinical Study. [PDF]

Vaccines (Basel)
Wang Y, Shi G, Wang X, Xie Z, Gou J, Huang L, Huang H, You W, Wang R, Yang Y, Wang F, Zhu T, Zhao D.   +12 more
europepmc   +1 more source

Case Series of Streptococcus pneumoniae Keratitis and Its Sequelae. [PDF]

Cureus
Saffian N, Ngoo QZ, Muhammed J.
europepmc   +1 more source

Endolysins: targeting <i>Streptococcus pneumoniae</i> in its major anatomical niches of infection and addressing the hurdles. [PDF]

Front Microbiol
Castallanos G, Gonzalez-Juarbe N, Nelson DC.   +2 more
europepmc   +1 more source